Puma Biotechnology Inc investor relations material

Listen to the latest call from Puma Biotechnology Inc

Puma Biotechnology, Inc. is a biopharmaceutical company focused on the development and commercialization of products to enhance cancer care in the United States and internationally. The company is focused on late-stage development of tarextumab tetraxetan for the treatment of certain advanced cancers, as well as development and commercialization of bevasiranib phosphate for the treatment of gastrointestinal stromal tumors (GIST).

Dig deeper into the Puma Biotechnology Inc fundamentals on Quartr.